Bevacizumab (Avastin) for metastatic gastric cancer - first line in combination with capecitabine and cisplatin
National Horizon Scanning Centre
Record ID 32010000555
English
Details
Project Status:
Completed
URL for project:
http://www.nhsc-healthhorizons.org.uk/topics/bevacizumab-avastin-in-combination-with-capecitabi/
Year Published:
2008
URL for published report:
n/a
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Angiogenesis Inhibitors
- Antibodies, Monoclonal
- Antineoplastic Agents
- Antineoplastic Combined Chemotherapy Protocols
- Cisplatin
- Deoxycytidine
- Neoplasm Metastasis
- Stomach Neoplasms
- Capecitabine
- Bevacizumab
Contact
Organisation Name:
NIHR Horizon Scanning Centre
Contact Address:
The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health and Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831, Fax: +44 121 2269
Contact Name:
c.packer@bham.ac.uk
Contact Email:
c.packer@bham.ac.uk
Copyright:
NIHR Horizon Scanning Centre (NIHR HSC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.